Neuralport Inc. (Headquarters: Ashiya City, Hyogo Prefecture; CEO: Anna Shimafuji) is pleased to announce that it has implemented a third-party allotment of new shares to Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. and angel investors, along with debt financing from Japan Finance Corporation, during its seed extension round, bringing the total amount raised to 170 million yen.
Company Overview
[About Neuralport Inc.] Under the mission 'Update the Brain OS,' Neuralport Inc. is engaged in the research and development of the VR brain fatigue measurement system 'ZEN EYE Pro' and the ZONE training pod 'ZONE-Z,' which scientifically reproduces the 'ZONE' (flow) state, targeting high performers, primarily athletes. The company has formed a global team centered on cross-disciplinary research spanning experimental psychology, brain science, eye-tracking, and robotics.
Company Name: Neuralport Inc. Location: Parti Ashiya II 2F, 1-8 Iwazono-cho, Ashiya City, Hyogo Prefecture Representative: CEO Anna Shimafuji Established: September 2020 Capital: 48,700,000 yen Website: https://neuralport.io Business Description: R&D of the brain fatigue measurement system 'ZEN EYE Pro' using eye-tracking technology, and R&D of the ZONE training pod 'ZONE-Z'.
[Inquiries regarding this matter] Neuralport Inc. Inquiry Desk: info@neuralport.jp
FACT BOX
- Source: PR TIMES
- Category: Funding
- Products / services: ZEN EYE Pro / ZONE-Z